Reveal registry: Baseline characteristics of the first 1,226 enrolled patients

被引：0
|
作者：
Badesch, David B. [1 ]
Benza, Raymond L. [1 ]
Krichman, Abby M. [1 ]
Raskob, Gary E. [1 ]
Giles, Scott [1 ]
机构：
[1] Univ Colorado, Hlth Sci Ctr, Denver, CO USA
来源：
CHEST | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：473S / 474S
页数：2
相关论文
共 50 条
  • [41] Baseline characteristics of patients enrolled in the phase III trial of rhAPC in severe sepsis
    LaRosa, SP
    Vincent, JL
    Bellomo, R
    Russell, JA
    Laterre, PF
    Artigas, A
    Van Der Linden, CJ
    Dhainaut, JF
    Riess, H
    Brown, JM
    Knobel, E
    Bernard, GR
    CRITICAL CARE MEDICINE, 2000, 28 (12) : A48 - A48
  • [42] Baseline characteristics of patients enrolled in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL)
    Mentz, Robert J.
    Bethel, M. Angelyn
    Gustavson, Stephanie
    Thompson, Vivian P.
    Pagidipati, Neha J.
    Buse, John B.
    Chan, Juliana C.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Marso, Steve P.
    Ohman, Peter
    Poulter, Neil
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    Holman, Rury R.
    AMERICAN HEART JOURNAL, 2017, 187 : 1 - 9
  • [43] Baseline characteristics of initial patients in the CorEvitas SPHERES registry for NMOSD
    Gholizadeh, S.
    Exuzides, A.
    Sidiropoulos, P.
    Middaugh, N.
    Crabtree, M. M.
    Cronin, A.
    Pappas, D. A.
    Behne, J.
    Bennett, J. L.
    Blaschke, T. F.
    Cook, L. J.
    Levy, M.
    Lewis, K. E.
    Smith, T. J.
    Weinshenker, B.
    Wingerchuk, D.
    Yeaman, M. R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 414 - 415
  • [44] Characteristics of the New Childhood Arthritis and Rheumatology Research Alliance Registry of Juvenile Myositis Patients Enrolled in the First Two Years
    Neely, Jessica
    Huber, Adam
    Kim, Susan
    ARTHRITIS & RHEUMATOLOGY, 2020, 72 : 205 - 207
  • [45] Pulmonary Arterial Hypertension in the Elderly: Baseline Characteristics and Evaluation of Therapeutics. An Examination of the Reveal Registry
    Test, V. J.
    Farber, H. W.
    McGoon, M. D.
    Parsons, L.
    Channick, R. N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [46] THE CHARACTERISTICS AND INITIAL DISEASE OBSERVATIONS OF PATIENTS ENROLLED IN THE PERTH LUPUS REGISTRY (PLR)
    Ognjenovic, Milica
    Raymond, Warren
    Cheah, Patrick
    Chakera, Aron
    McLean-Tooke, Andrew
    Nossent, Johannes
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 44 - 44
  • [47] Characteristics and outcomes of patients with a history of cancer enrolled in our prospective HFpEF registry
    Kronberger, C.
    Alvieva, E.
    List, L.
    Poledniczek, M.
    Kokabi, V
    Spannbauer, A.
    Willixhofer, R.
    Ermolaev, N.
    Duca, F.
    Rettl, R.
    Binder-Rodriguez, C.
    Badr Eslam, R.
    Kastner, J.
    Kammerlander, A.
    Bergler-Klein, J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [48] ABSORB FIRST: An interim report on baseline characteristics and acute performance on the first 1,200 patients from a prospective, multi-center, global registry
    Eeckhout, Eric
    Seth, Ashok
    Mao, Vivian W.
    Gao, Yuan
    Cheong, Wai-Fung
    Staehr, Peter
    Naber, Christoph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B179 - B179
  • [49] Baseline characteristics of the first one hundred and two patients enrolled in the trial DAPAgliflozin for Renal protection in Heart Transplant recipients (DAPARHT)
    Holmen, S.
    Gude, E.
    Bjorkelund, E.
    Andreassen, A.
    Ravnestad, H.
    Manintveld, O.
    Braun, O.
    Haugen-Lofman, I.
    Gullestad, L.
    Broch, K.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 : 296 - 297
  • [50] Better implant survival with modern ankle prosthetic designs: 1,226 total ankle prostheses followed for up to 20 years in the Swedish Ankle Registry
    Unden, Alexandra
    Jehpsson, Lars
    Kamrad, Ilka
    Carlsson, Ake
    Henricson, Anders
    Karlsson, Magnus K.
    Rosengren, Bjorn E.
    ACTA ORTHOPAEDICA, 2020, 91 (02) : 191 - 196
12345